Lung pathology of fatal severe acute respiratory syndrome
- PMID: 12781536
- PMCID: PMC7112492
- DOI: 10.1016/s0140-6736(03)13413-7
Lung pathology of fatal severe acute respiratory syndrome
Abstract
Background: Severe acute respiratory syndrome (SARS) is a novel infectious disease with global impact. A virus from the family Coronaviridae has been identified as the cause, but the pathogenesis is still unclear.
Methods: Post-mortem tissue samples from six patients who died from SARS in February and March, 2003, and an open lung biopsy from one of these patients were studied by histology and virology. Only one full autopsy was done. Evidence of infection with the SARS-associated coronavirus (SARS-CoV) and human metapneumovirus was sought by reverse-transcriptase PCR and serology. Pathological samples were examined by light and electron microscopy and immunohistochemistry.
Findings: All six patients had serological evidence of recent infection with SARS-CoV. Diffuse alveolar damage was common but not universal. Morphological changes identified were bronchial epithelial denudation, loss of cilia, and squamous metaplasia. Secondary bacterial pneumonia was present in one case. A giant-cell infiltrate was seen in four patients, with a pronounced increase in macrophages in the alveoli and the interstitium of the lung. Haemophagocytosis was present in two patients. The alveolar pneumocytes also showed cytomegaly with granular amphophilic cytoplasm. The patient for whom full autopsy was done had atrophy of the white pulp of the spleen. Electron microscopy revealed viral particles in the cytoplasm of epithelial cells corresponding to coronavirus.
Interpretation: SARS is associated with epithelial-cell proliferation and an increase in macrophages in the lung. The presence of haemophagocytosis supports the contention that cytokine dysregulation may account, at least partly, for the severity of the clinical disease. The case definition of SARS should acknowledge the range of lung pathology associated with this disease.
Figures
Similar articles
-
[Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies].Zhonghua Bing Li Xue Za Zhi. 2005 Oct;34(10):656-60. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16536279 Chinese.
-
[Clinical pathology and pathogenesis of severe acute respiratory syndrome].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Sep;17(3):217-21. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003. PMID: 15340561 Chinese.
-
[Severe acute respiratory syndrome (SARS)--new, unknown disease?].Pol Merkur Lekarski. 2004 Feb;16(92):183-7. Pol Merkur Lekarski. 2004. PMID: 15176307 Review. Polish.
-
SARS: clinical virology and pathogenesis.Respirology. 2003 Nov;8 Suppl(Suppl 1):S6-8. doi: 10.1046/j.1440-1843.2003.00517.x. Respirology. 2003. PMID: 15018126 Free PMC article. Review.
-
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore.Hum Pathol. 2003 Aug;34(8):743-8. doi: 10.1016/s0046-8177(03)00367-8. Hum Pathol. 2003. PMID: 14506633 Free PMC article.
Cited by
-
S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-κB and improving mitochondrial oxidative phosphorylation.J Transl Med. 2024 Jun 5;22(1):535. doi: 10.1186/s12967-024-05220-9. J Transl Med. 2024. PMID: 38840216 Free PMC article.
-
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses.J Nanobiotechnology. 2024 May 31;22(1):304. doi: 10.1186/s12951-024-02573-7. J Nanobiotechnology. 2024. PMID: 38822339 Free PMC article. Review.
-
Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review.Food Sci Hum Wellness. 2022 Sep;11(5):1134-1142. doi: 10.1016/j.fshw.2022.04.005. Epub 2022 Jun 2. Food Sci Hum Wellness. 2022. PMID: 38621001 Free PMC article. Review.
-
[Intensive care during the 2019-coronavirus epidemic].Med Intensiva. 2020 Aug-Sep;44(6):351-362. doi: 10.1016/j.medin.2020.03.001. Epub 2020 Mar 30. Med Intensiva. 2020. PMID: 38620515 Free PMC article. Review. Spanish.
-
Coronavirus and the Cytoskeleton of Virus-Infected Cells.Subcell Biochem. 2023;106:333-364. doi: 10.1007/978-3-031-40086-5_12. Subcell Biochem. 2023. PMID: 38159233
References
-
- WHO Cumulative number of reported cases of severe acute respiratory syndrome. (SARS) http://www.who.int/csr/sarscountry/2003_04_05/en (accessed May 6, 2003).
-
- Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med (in press). - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith C, et-al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (in press). - PubMed
-
- Poutanen SM, Low DE, Henry B, et-al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med (in press). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous